Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-387,450
Closed -$29.3M 391
2026
Q1
$29.3M Buy
387,450
+287,450
+287% +$21.6M 0.56% 36
2025
Q4
$7.45M Buy
+100,000
New +$7.31M 0.16% 139
2024
Q1
Sell
-3,669
Closed -$262K 632
2023
Q4
$262K Buy
+3,669
New +$255K 0.01% 841
2023
Q3
Sell
-3,816
Closed -$309K 1146
2023
Q2
$309K Buy
+3,816
New +$312K ﹤0.01% 725

Other funds holding HOLX

Maven Securities's HOLX Position: Q2 2026 in Review

Maven Securities sold out of Hologic (HOLX) in Q2 2026, closing a stake of 387,450 shares — an estimated $29.3M sold.

Maven Securities first reported a position in HOLX in Q2 2023 and held it in 4 quarters. The position peaked at $29.3M in Q1 2026. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Maven Securities reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Maven Securities sold 387,450 Hologic shares in Q2 2026, an estimated $29.3M.
  • Maven Securities first reported a position in Hologic in Q2 2023 and held it in 4 quarters.
  • Maven Securities's Hologic position peaked at $29.3M in Q1 2026.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Maven Securities's 13F filing for Q2 2026, filed 14 Aug 2026.